Limited Dose Rate Brachytherapy Monotherapy: Inadequate for NCCN UIR Prostate Cancer Patients

1 year ago 70
The following is a summary of “LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients,” published...
Read Entire Article